Refined Processes LLC
Native American Cannabis Company Partners with Extraction Tech Leader to Achieve FDA and EU GMP Compliance
This strategic move positions Refined to capitalize on the imminent rescheduling of marijuana as a Schedule III controlled substance by the DEA, which would allow for interstate commerce and international distribution of cannabis-based pharmaceuticals.